NS Partners’s Celgene Corp CELG Stock Holding History

NS Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19,817	Closed	-$1.77M	–	100
2018 Q3	$1.77M	Sell	19,817 -25	-0.1%	-$2.21K	0.17%	85
2018 Q2	$1.58M	Sell	19,842 -200	-1%	-$16.6K	0.16%	89
2018 Q1	$1.79M	Sell	20,042 -701	-3%	-$67.3K	0.19%	90
2017 Q4	$2.17M	Buy	20,743 +230	+1%	+$26K	0.24%	89
2017 Q3	$2.99M	Sell	20,513 -36	-0.2%	-$4.9K	0.36%	80
2017 Q2	$2.67M	Buy	20,549 +1,433	+7%	+$176K	0.35%	75
2017 Q1	$2.38M	Sell	19,116 -20,834	-52%	-$2.49M	0.34%	78
2016 Q4	$4.62M	Buy	39,950 +527	+1%	+$58.7K	0.73%	61
2016 Q3	$4.12M	Sell	39,423 -55	-0.1%	-$5.95K	0.67%	66
2016 Q2	$3.89M	Buy	39,478 +240	+0.6%	+$24.8K	0.66%	65
2016 Q1	$3.93M	Buy	39,238 +474	+1%	+$48.8K	0.71%	62
2015 Q4	$4.64M	Sell	38,764 -1,906	-5%	-$221K	0.83%	54
2015 Q3	$4.4M	Sell	40,670 -932	-2%	-$116K	0.77%	60
2015 Q2	$4.82M	Buy	+41,602	New	+$4.76M	0.77%	63

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NS Partners's CELG Position: Q4 2018 in Review

NS Partners sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 19,817 shares — an estimated $1.77M sold.

NS Partners first reported a position in CELG in Q2 2015 and held it in 14 quarters. The position peaked at $4.82M in Q2 2015. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

NS Partners reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
NS Partners sold 19,817 Celgene Corp shares in Q4 2018, an estimated $1.77M.
NS Partners first reported a position in Celgene Corp in Q2 2015 and held it in 14 quarters.
NS Partners's Celgene Corp position peaked at $4.82M in Q2 2015.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on NS Partners's 13F filing for Q4 2018, filed 12 Feb 2019.